dr. o'brien discusses duvelisib in cll
Published 5 years ago • 740 plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
2:22
dr. o'brien discusses ibrutinib and idelalisib in cll
-
2:03
dr. o'brien discusses the standard of care for cll
-
0:51
dr. o'brien discusses combination venetoclax in cll
-
0:52
dr. tam discusses the side effect profile of duvelisib in cll
-
1:17
dr. susan o'brien compares ibrutinib and chemoimmunotherapy in frontline cll
-
1:53
dr. rosenblatt discusses promise of duvelisib in cll
-
1:19
a study of duvelisib vs ofatumumab in relapsed/refractory cll
-
1:19
duvelisib in relapsed/refractory cll
-
1:00
dr. jennifer brown on duvelisib in cll
-
1:31
dr. leslie discusses duvelisib in follicular lymphoma
-
0:57
dr. grossbard on the dynamo study with duvelisib in follicular lymphoma
-
5:50
idelalisib in chronic lymphocytic leukemia
-
2:45
cll: the rapidly evolving treatment landscape
-
1:06
dr. flinn on the fda approval of duvelisib in cll and follicular lymphoma
-
27:34
discussion on current issues in chronic lymphocytic leukemia (cll)
-
1:37
duvelisib and fcr: a recipe for success in cll
-
4:18
duvelisib in car t-cell therapy for cll
-
2:36
duo trial: duvelisib for cll/sll
-
2:04
dr. mato discusses a phase ii trial of umbralisib in cll